Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Rx DRUG PRICES AT PRODUCER LEVEL UP 2.8% IN FIRST QUARTER

Executive Summary

Rx DRUG PRICES AT PRODUCER LEVEL UP 2.8% IN FIRST QUARTER, the most modest first quarter gain in over 10 years, according to data from the Bureau of Labor Statistics' Producer Price Index. First quarter price inflation has generally been in the 4-4.5% range during the 1980s; the next smallest first quarter gain during the decade was 3% in 1988. PPI data was released by the Bureau of Labor Statistics on April 13. Drug categories showing the biggest first quarter price increases include hormones (up 9.8%), systemic antihistamines (up 7.3%), muscle relaxants (up 7.1%), major tranquilizers (up 6.1%), cardiovasculars other than vasodilators and antihypertensives (up 5.8%), aspirin, APC and related products (up 5.6%), and dermatological preparations and diuretics (both up 5%). Among the therapeutic categories showing price decreases for the period were ophthalmic and otic preparations (down 1.8%), anticonvulsants (down 0.8%), systemic anti-infectives (down 0.2%), and broad and medium spectrum antibiotics (down 0.2%).
UsernamePublicRestriction

Register

PS017307

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel